NKAIN1, as an oncogene, promotes the proliferation and metastasis of breast cancer, affecting its prognosis

Abstract

AbstractNa, K‐ATPase interaction (NKAIN) is a transmembrane protein family, which can interact with Na, K‐ATPase β1 subunit. NKAIN1 plays an important role in alcohol‐dependent diseases such as endometrial and prostate cancers. However, the relationship between NKAIN1 and human breast cancer has not been studied. Hence, this study aimed to explore the relationship between NKAIN1 expression and breast cancer. Data used in this study were mainly from the Cancer Genome Atlas, including differential expression analysis, Kaplan–Meier survival analysis, receiver operating characteristic curve analysis, multiple Cox regression analysis, co‐expression gene analysis, and gene set enrichment analysis. Analyses were performed using reverse transcription‐quantitative polymerase chain reaction, western blot analysis, and immunohistochemistry on 46 collected samples. The knockdown or overexpression of NKAIN1 in vitro in MCF‐7 and MDA‐MB‐231 cell lines altered the proliferation and migration abilities of tumor cells. In vivo experiments further confirmed that NKAIN1 knockdown effectively inhibited the proliferation and migration of cancer cells. Therefore, our study identified NKAIN1 as an oncogene that is highly expressed in breast cancer tissues. The findings highlight the potential of NKAIN1 as a molecular biomarker of breast cancer.